Yann Echelard insider trades: Tg Therapeutics (TGTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Yann reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | TGTX | ↓ Sell | 5,000 | $32.57 | $163K | Direct | Nov 25, 2025 (1d) |
| Jun 13, 2025 | TGTX | ↓ Sell | 10,000 | $36.94 | $369K | Direct | Jun 16, 2025 (3d) |
| Nov 5, 2024 | TGTX | ↓ Sell | 20,000 | $24.48 | $490K | Direct | Nov 7, 2024 (2d) |
| Jan 6, 2023 | TGTX | ↑ Buy | 9,000 | $10.64 | $96K | Direct | Jan 6, 2023 (0d) |
| Dec 10, 2020 | TGTX | ↓ Sell | 30,000 | $40.05 | $1.2M | Direct | Dec 11, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TGTX insiders
Open-market trades in the last 12 months
About Yann Echelard's insider trades
Yann Echelard is a director at Tg Therapeutics (TGTX). Since Dec 10, 2020, Yann has reported 1 open-market purchase worth $96K and 4 sales worth $2.2M on SEC Form 4. In the last 12 months: 1 sale ($163K).
Their filings also include grants and awards (15 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TGTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.